United States· US:66096-787_d450b732-cb2c-7416-e053-2995a90a2c2e
Argentum Metallicum
A silver product containing silver, registered in United States by OHM PHARMA INC.. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Silver is registered in 2 of 19 countries.
Countries holding a registration under ATC D08AL30 (silver), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Silver · ATC D08AL30
2 / 19 countries
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SILVER
- Manufacturer
- OHM PHARMA INC.
- Country
- United States (US)
- ATC code
- D08AL30
- ATC class
- Silver
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1166096-787-01
- ndc1166096787016 [hp_C] in 1 TUBE (66096-787-01)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
23 interactions on record for silver.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Silver · interactions on record
23 records
- 1 severe
- 22 moderate
Most severe, free to view
- PrilocaineN01BB04severe
- LidocainA01AE01moderate
- TetracainA01AE02moderate
- LidocaineC05AD01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Silver in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumArgentum Metallicum Boiron 200KBoiron
- United KingdomAvoca 40% silver nitrate pencilsBray Group Ltd
- NetherlandsArgentum metallicumHeel Belgium n.v.
- NorwayArzolArzol chemical
- FinlandARGENTUM Alfaplex (Ulcusin Alfaplex)
- FranceGRANIONS D'ARGENT 0,68 mg/2 ml, solution buvableGRANIONS
- Japan硝酸銀
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Spain · Argenpal
- France · D'argent Granions, Nitrate D’argent Cooper
- United Kingdom (Northern Ireland) · Avoca Caustic Applicator, Avoca Caustic Pencil
- Malta · Avoca Caustic Applicator, Silver Nitrate Caustic Applicator Bray Group
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c0fe8e2b-de2a-4433-ba65-8485ed19851d GET /v1/drugs/c0fe8e2b-de2a-4433-ba65-8485ed19851d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "6",
"substance": "SILVER",
"productndc": "66096-787",
"dosage_form": "PELLET",
"dea_schedule": null,
"strength_unit": "[hp_C]/6[hp_C]",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about silver.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.